Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

SZSE:002932 Stock Report

Market Cap: CN¥4.8b

Wuhan Easy Diagnosis BiomedicineLtd Past Earnings Performance

Past criteria checks 2/6

Wuhan Easy Diagnosis BiomedicineLtd has been growing earnings at an average annual rate of 55.6%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 60.9% per year. Wuhan Easy Diagnosis BiomedicineLtd's return on equity is 9%, and it has net margins of 14%.

Key information

55.6%

Earnings growth rate

54.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate60.9%
Return on equity9.0%
Net Margin14.0%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Mar 07
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Revenue & Expenses Breakdown
Beta

How Wuhan Easy Diagnosis BiomedicineLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002932 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 233,686515754340
30 Jun 235,8151,561824403
31 Mar 238,4152,895919393
31 Dec 2210,5304,208955388
30 Sep 228,3614,246441209
30 Jun 226,9423,594400140
31 Mar 224,6402,461345139
01 Jan 222,8301,413294133
30 Sep 212,2571,118233114
30 Jun 211,740848207100
31 Mar 211,60880817486
31 Dec 2095946912970
30 Sep 206823539347
30 Jun 204402017740
31 Mar 20163276436
31 Dec 19181426437
30 Sep 19184585936
30 Jun 19180635734
31 Mar 19186645630
31 Dec 18176615227
30 Sep 18180674724
30 Jun 18179703035
31 Mar 18172684731
31 Dec 17165653926
30 Sep 17154614218
30 Jun 1715863600
31 Mar 1713855410
31 Dec 1614160520
30 Sep 1613054490
30 Jun 1612048450
31 Mar 1610742390
31 Dec 159536330
30 Sep 158733280
30 Jun 157931220
31 Mar 156826200
31 Dec 145822180
30 Sep 144918160
30 Jun 144015130
31 Mar 143311110
31 Dec 13267100

Quality Earnings: 002932 has high quality earnings.

Growing Profit Margin: 002932's current net profit margins (14%) are lower than last year (50.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002932's earnings have grown significantly by 55.6% per year over the past 5 years.

Accelerating Growth: 002932's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002932 had negative earnings growth (-87.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.3%).


Return on Equity

High ROE: 002932's Return on Equity (9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.